"Analysis.group","Analysis.number","Analysis.name","Subgroup","Applicability","Study","Study.year","GIV.Mean","GIV.SE","Experimental.mean","Experimental.SD","Experimental.cases","Experimental.N","Control.mean","Control.SD","Control.cases","Control.N","O.E","Variance","Weight","Mean","CI.start","CI.end","Footnotes","review.url","review.doi","analysis_key","dataset_name","mismatch_type","direction_match","or_sig","rd_sig","log_or","rd","log_or_ci_lb","log_or_ci_ub","rd_ci_lb","rd_ci_ub","sparse_events","double_zero"
1,1,"SAEs","Interferon beta-1b versus placebo","SUBGROUP_AND_OVERALL","NASP 2004",2004,0,0,0,0,174,631,0,0,86,308,0,0,100,0.98758,0.792938,1.229999,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Interferon beta-1a (Avonex) versus placebo","SUBGROUP_AND_OVERALL","BRAVO 2014",2014,0,0,0,0,34,442,0,0,54,449,0,0,33.618223,0.639601,0.425107,0.962322,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Interferon beta-1a (Avonex) versus placebo","SUBGROUP_AND_OVERALL","CHAMPS 2000",2000,0,0,0,0,12,193,0,0,19,190,0,0,21.8722,0.621762,0.310494,1.245073,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Interferon beta-1a (Avonex) versus placebo","SUBGROUP_AND_OVERALL","Kappos 2011",2011,0,0,0,0,2,54,0,0,2,54,0,0,4.791492,1,0.14612,6.843682,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Interferon beta-1a (Avonex) versus placebo","SUBGROUP_AND_OVERALL","MSCRG 1996",1996,0,0,0,0,25,158,0,0,14,143,0,0,24.761773,1.616184,0.874738,2.986097,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Interferon beta-1a (Avonex) versus placebo","SUBGROUP_AND_OVERALL","Pakdaman 2007",2007,0,0,0,0,9,104,0,0,7,98,0,0,14.956312,1.211538,0.469299,3.127696,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Interferon beta-1a (Rebif) versus placebo","SUBGROUP_AND_OVERALL","Andersen 2004",2004,0,0,0,0,51,186,0,0,49,178,0,0,37.552751,0.99605,0.713301,1.39088,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Interferon beta-1a (Rebif) versus placebo","SUBGROUP_AND_OVERALL","Boyko 2017",2017,0,0,0,0,0,109,0,0,3,54,0,0,1.24743,0.071429,0.003756,1.358524,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Interferon beta-1a (Rebif) versus placebo","SUBGROUP_AND_OVERALL","ETOMS 2001",2001,0,0,0,0,6,154,0,0,5,155,0,0,7.168178,1.207792,0.376482,3.874717,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Interferon beta-1a (Rebif) versus placebo","SUBGROUP_AND_OVERALL","IMPROVE 2010",2010,0,0,0,0,4,60,0,0,3,120,0,0,4.747545,2.666667,0.616505,11.53456,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Interferon beta-1a (Rebif) versus placebo","SUBGROUP_AND_OVERALL","OWIMS 1999",1999,0,0,0,0,11,193,0,0,3,100,0,0,6.299479,1.899827,0.54238,6.654641,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Interferon beta-1a (Rebif) versus placebo","SUBGROUP_AND_OVERALL","PRISMS 1998",1998,0,0,0,0,44,373,0,0,25,187,0,0,28.125139,0.882359,0.557916,1.395476,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Interferon beta-1a (Rebif) versus placebo","SUBGROUP_AND_OVERALL","REFLEX 2012",2012,0,0,0,0,14,344,0,0,12,171,0,0,14.859479,0.579942,0.274241,1.226411,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Glatiramer acetate versus placebo","SUBGROUP_AND_OVERALL","Boyko 2016",2016,0,0,0,0,8,126,0,0,1,32,0,0,1.15154,2.031746,0.263571,15.661799,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Glatiramer acetate versus placebo","SUBGROUP_AND_OVERALL","CONFIRM 2012",2012,0,0,0,0,60,351,0,0,79,363,0,0,52.710843,0.785459,0.580797,1.06224,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Glatiramer acetate versus placebo","SUBGROUP_AND_OVERALL","Comi 2001",2001,0,0,0,0,10,119,0,0,6,120,0,0,5.002832,1.680672,0.630873,4.477382,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Glatiramer acetate versus placebo","SUBGROUP_AND_OVERALL","GALA 2013",2013,0,0,0,0,42,943,0,0,21,461,0,0,18.333978,0.977731,0.586042,1.63121,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Glatiramer acetate versus placebo","SUBGROUP_AND_OVERALL","GATE 2015",2015,0,0,0,0,29,710,0,0,2,84,0,0,2.399138,1.715493,0.416763,7.06137,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Glatiramer acetate versus placebo","SUBGROUP_AND_OVERALL","Johnson 1995",1995,0,0,0,0,2,125,0,0,0,126,0,0,0.524437,5.039683,0.244387,103.926962,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Glatiramer acetate versus placebo","SUBGROUP_AND_OVERALL","PreCISe 2009",2009,0,0,0,0,11,243,0,0,19,238,0,0,9.246582,0.567035,0.275803,1.16579,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Glatiramer acetate versus placebo","SUBGROUP_AND_OVERALL","Wolinsky 2007",2007,0,0,0,0,22,627,0,0,13,316,0,0,10.63065,0.852901,0.435487,1.670409,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Natalizumab versus placebo","SUBGROUP_AND_OVERALL","AFFIRM 2006",2006,0,0,0,0,81,627,0,0,34,312,0,0,33.045126,1.185477,0.813309,1.727949,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Natalizumab versus placebo","SUBGROUP_AND_OVERALL","ASCEND 2018",2018,0,0,0,0,90,439,0,0,100,449,0,0,59.924606,0.920501,0.715047,1.184988,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Natalizumab versus placebo","SUBGROUP_AND_OVERALL","Miller 2003",2003,0,0,0,0,8,142,0,0,7,71,0,0,5.876252,0.571429,0.215851,1.512761,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Natalizumab versus placebo","SUBGROUP_AND_OVERALL","Saida 2017",2017,0,0,0,0,3,47,0,0,1,47,0,0,1.154016,3,0.323631,27.809466,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Azathioprine versus placebo","SUBGROUP_AND_OVERALL","British and Dutch 1988",1988,0,0,0,0,7,174,0,0,2,180,0,0,100,3.62069,0.762672,17.188761,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Immunoglobulins versus placebo","SUBGROUP_AND_OVERALL","Fazekas 2008",2008,0,0,0,0,4,86,0,0,3,41,0,0,59.915414,0.635659,0.149107,2.709876,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Immunoglobulins versus placebo","SUBGROUP_AND_OVERALL","Lewanska 2002",2002,0,0,0,0,0,32,0,0,0,17,0,0,NA,NA,NA,NA,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Immunoglobulins versus placebo","SUBGROUP_AND_OVERALL","Pohlau 2007",2007,0,0,0,0,4,116,0,0,1,115,0,0,40.084586,3.965517,0.450031,34.942769,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Fingolimod versus placebo","SUBGROUP_AND_OVERALL","FREEDOMS 2010",2010,0,0,0,0,94,854,0,0,56,418,0,0,23.586905,0.821596,0.602912,1.119598,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Fingolimod versus placebo","SUBGROUP_AND_OVERALL","FREEDOMS II 2014",2014,0,0,0,0,106,728,0,0,45,355,0,0,21.936379,1.148657,0.830085,1.589491,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Fingolimod versus placebo","SUBGROUP_AND_OVERALL","INFORMS 2016",2016,0,0,0,0,122,483,0,0,117,487,0,0,37.18293,1.051371,0.843593,1.310324,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Fingolimod versus placebo","SUBGROUP_AND_OVERALL","Kappos 2006",2006,0,0,0,0,51,188,0,0,25,93,0,0,15.192802,1.009149,0.670424,1.519011,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Fingolimod versus placebo","SUBGROUP_AND_OVERALL","Saida 2012",2012,0,0,0,0,16,111,0,0,3,57,0,0,2.100985,2.738739,0.832317,9.011822,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Teriflunomide versus placebo","SUBGROUP_AND_OVERALL","O'Connor 2006",2006,0,0,0,0,12,122,0,0,7,57,0,0,5.408002,0.800937,0.333044,1.926172,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Teriflunomide versus placebo","SUBGROUP_AND_OVERALL","TEMSO 2011",2011,0,0,0,0,109,726,0,0,46,360,0,0,40.512114,1.174991,0.852698,1.6191,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Teriflunomide versus placebo","SUBGROUP_AND_OVERALL","TOPIC 2014",2014,0,0,0,0,42,423,0,0,18,191,0,0,15.105235,1.053586,0.623219,1.781143,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Teriflunomide versus placebo","SUBGROUP_AND_OVERALL","TOWER 2014",2014,0,0,0,0,96,780,0,0,47,385,0,0,38.974649,1.008183,0.727077,1.397972,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Dimethyl fumarate versus placebo","SUBGROUP_AND_OVERALL","APEX 2019",2019,0,0,0,0,15,111,0,0,16,113,0,0,6.604926,0.954392,0.496297,1.835321,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Dimethyl fumarate versus placebo","SUBGROUP_AND_OVERALL","CONFIRM 2012",2012,0,0,0,0,115,703,0,0,79,363,0,0,42.801397,0.751661,0.581385,0.971807,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Dimethyl fumarate versus placebo","SUBGROUP_AND_OVERALL","DEFINE 2012",2012,0,0,0,0,139,826,0,0,86,408,0,0,48.493186,0.798356,0.627176,1.016256,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Dimethyl fumarate versus placebo","SUBGROUP_AND_OVERALL","FUMAPMS 2021",2021,0,0,0,0,2,27,0,0,2,27,0,0,0.793996,1,0.151681,6.592787,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Dimethyl fumarate versus placebo","SUBGROUP_AND_OVERALL","Kappos 2008",2008,0,0,0,0,4,191,0,0,3,65,0,0,1.306495,0.453752,0.104303,1.973971,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Daclizumab versus placebo","SUBGROUP_AND_OVERALL","SELECT 2013",2013,0,0,0,0,68,417,0,0,53,204,0,0,100,0.627664,0.45683,0.862383,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Laquinimod versus placebo","SUBGROUP_AND_OVERALL","ALLEGRO 2012",2012,0,0,0,0,61,550,0,0,53,556,0,0,34.648388,1.163499,0.821006,1.648868,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Laquinimod versus placebo","SUBGROUP_AND_OVERALL","ARPEGGIO 2020",2020,0,0,0,0,10,138,0,0,6,140,0,0,4.346149,1.690821,0.631775,4.525146,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Laquinimod versus placebo","SUBGROUP_AND_OVERALL","BRAVO 2014",2014,0,0,0,0,42,433,0,0,54,449,0,0,29.012822,0.806518,0.550986,1.180559,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Laquinimod versus placebo","SUBGROUP_AND_OVERALL","CONCERTO 2022",2022,0,0,0,0,57,727,0,0,43,740,0,0,28.798382,1.349285,0.920482,1.977845,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Laquinimod versus placebo","SUBGROUP_AND_OVERALL","Comi 2008",2008,0,0,0,0,8,204,0,0,2,102,0,0,1.796569,2,0.432574,9.24698,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Laquinimod versus placebo","SUBGROUP_AND_OVERALL","Polman 2005",2005,0,0,0,0,3,142,0,0,1,67,0,0,0.836102,1.415493,0.150022,13.355499,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Laquinimod versus placebo","SUBGROUP_AND_OVERALL","Ziemssen 2017",2017,0,0,0,0,1,84,0,0,1,28,0,0,0.561589,0.333333,0.021553,5.155164,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Pegylated interferon beta-1a versus placebo","SUBGROUP_AND_OVERALL","ADVANCE 2014",2014,0,0,0,0,50,1012,0,0,23,500,0,0,100,1.074068,0.663256,1.739332,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Cladribine versus placebo","SUBGROUP_AND_OVERALL","CLARITY 2010",2010,0,0,0,0,77,884,0,0,28,435,0,0,54.354055,1.353224,0.891783,2.053431,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Cladribine versus placebo","SUBGROUP_AND_OVERALL","ORACLE 2014",2014,0,0,0,0,33,410,0,0,21,206,0,0,45.645945,0.789547,0.468989,1.329211,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Rituximab versus placebo","SUBGROUP_AND_OVERALL","Hauser 2008",2008,0,0,0,0,9,69,0,0,5,35,0,0,18.550572,0.913043,0.330976,2.518756,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Rituximab versus placebo","SUBGROUP_AND_OVERALL","OLYMPUS 2009",2009,0,0,0,0,47,292,0,0,20,147,0,0,81.449428,1.183048,0.728931,1.920076,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Ocrelizumab versus placebo","SUBGROUP_AND_OVERALL","Kappos 2011",2011,0,0,0,0,4,110,0,0,2,54,0,0,3.050151,0.981818,0.185594,5.193948,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Ocrelizumab versus placebo","SUBGROUP_AND_OVERALL","ORATORIO 2017",2017,0,0,0,0,99,486,0,0,53,239,0,0,96.949849,0.918588,0.683593,1.234367,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Azathioprine versus interferons","SUBGROUP_AND_OVERALL","MAIN TRIAL 2014",2014,0,0,0,0,6,69,0,0,3,77,0,0,100,2.231884,0.580169,8.585953,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Natalizumab versus fingolimod","SUBGROUP_AND_OVERALL","REVEAL 2020",2020,0,0,0,0,0,54,0,0,2,54,0,0,100,0.2,0.009826,4.07078,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Fingolimod versus interferon beta-1b","SUBGROUP_AND_OVERALL","GOLDEN 2017",2017,0,0,0,0,9,104,0,0,1,47,0,0,68.950554,4.067308,0.530423,31.188275,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Fingolimod versus interferon beta-1b","SUBGROUP_AND_OVERALL","MOVING 2020",2020,0,0,0,0,1,6,0,0,0,7,0,0,31.049446,3.428571,0.164727,71.361155,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Ofatumumab versus teriflunomide","SUBGROUP_AND_OVERALL","ASCLEPIOS I 2020",2020,0,0,0,0,48,465,0,0,38,462,0,0,53.812194,1.255008,0.836524,1.882846,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Ofatumumab versus teriflunomide","SUBGROUP_AND_OVERALL","ASCLEPIOS II 2020",2020,0,0,0,0,38,481,0,0,36,474,0,0,46.187806,1.040194,0.671369,1.611639,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Diroximel fumarate versus dimethyl fumarate","SUBGROUP_AND_OVERALL","EVOLVE-MS-2 2020",2020,0,0,0,0,4,253,0,0,3,251,0,0,100,1.322793,0.299098,5.850191,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Dimethyl fumarate versus glatiramer acetate","SUBGROUP_AND_OVERALL","CONFIRM 2012",2012,0,0,0,0,115,703,0,0,60,351,0,0,100,0.95697,0.719915,1.272084,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Ocrelizumab versus interferon beta 1a (Rebif)","SUBGROUP_AND_OVERALL","OPERA I 2017",2017,0,0,0,0,28,408,0,0,32,409,0,0,46.838796,0.877145,0.538278,1.42934,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Ocrelizumab versus interferon beta 1a (Rebif)","SUBGROUP_AND_OVERALL","OPERA II 2017",2017,0,0,0,0,29,417,0,0,40,417,0,0,53.161204,0.725,0.458441,1.14655,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Ozanimod versus interferon beta-1a (Avonex)","SUBGROUP_AND_OVERALL","RADIANCE 2019",2019,0,0,0,0,59,873,0,0,28,440,0,0,71.248697,1.062019,0.687448,1.640684,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Ozanimod versus interferon beta-1a (Avonex)","SUBGROUP_AND_OVERALL","SUNBEAM 2019",2019,0,0,0,0,29,901,0,0,11,445,0,0,28.751303,1.302089,0.656578,2.582229,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Fingolimod versus glatiramer acetate","SUBGROUP_AND_OVERALL","ASSESS 2020",2020,0,0,0,0,57,711,0,0,20,324,0,0,100,1.298734,0.793933,2.124499,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Rituximab versus glatiramer acetate","SUBGROUP_AND_OVERALL","Cheshmavar 2021",2021,0,0,0,0,0,43,0,0,0,41,0,0,NA,NA,NA,NA,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Interferon beta 1a (Rebif) versus interferon beta-1b","SUBGROUP_AND_OVERALL","AVANTAGE 2013",2013,0,0,0,0,1,65,0,0,2,150,0,0,22.087709,1.153846,0.106496,12.501479,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Interferon beta 1a (Rebif) versus interferon beta-1b","SUBGROUP_AND_OVERALL","REFORMS 2012",2012,0,0,0,0,4,65,0,0,5,64,0,0,77.912291,0.787692,0.221502,2.80114,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Siponimod versus placebo","SUBGROUP_AND_OVERALL","BOLD 2013",2013,0,0,0,0,17,235,0,0,0,61,0,0,26.868358,9.194915,0.560725,150.780717,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Siponimod versus placebo","SUBGROUP_AND_OVERALL","EXPAND 2018",2018,0,0,0,0,197,1099,0,0,83,546,0,0,73.131642,1.179188,0.932179,1.491649,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Cyclophosphamide versus corticosteroids","SUBGROUP_AND_OVERALL","PROMESS 2017",2017,0,0,0,0,16,72,0,0,13,66,0,0,100,1.128205,0.588282,2.163666,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Alemtuzumab versus interferon beta-1a (Rebif)","SUBGROUP_AND_OVERALL","CAMMS223 2008",2008,0,0,0,0,51,216,0,0,24,107,0,0,37.020177,1.052662,0.687332,1.612172,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Alemtuzumab versus interferon beta-1a (Rebif)","SUBGROUP_AND_OVERALL","CARE-MS I 2012",2012,0,0,0,0,51,376,0,0,14,187,0,0,23.659572,1.81174,1.029968,3.186896,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Alemtuzumab versus interferon beta-1a (Rebif)","SUBGROUP_AND_OVERALL","CARE-MS II 2012",2012,0,0,0,0,85,596,0,0,26,202,0,0,39.320251,1.108028,0.7359,1.668332,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Glatiramer acetate versus interferon beta-1a (Avonex)","SUBGROUP_AND_OVERALL","CombiRx 2013",2013,0,0,0,0,30,259,0,0,38,250,0,0,100,0.76204,0.487832,1.190381,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Laquinimod versus interferon beta-1a (Avonex)","SUBGROUP_AND_OVERALL","BRAVO 2014",2014,0,0,0,0,42,433,0,0,34,442,0,0,100,1.26097,0.818387,1.942902,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Daclizumab versus interferon beta-1a (Avonex)","SUBGROUP_AND_OVERALL","DECIDE 2015",2015,0,0,0,0,221,919,0,0,194,922,0,0,100,1.142894,0.964398,1.354427,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Glatiramer acetate versus interferon beta-1b","SUBGROUP_AND_OVERALL","BEYOND 2009",2009,0,0,0,0,57,445,0,0,238,1775,0,0,100,0.955292,0.72947,1.251023,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Teriflunomide versus interferon beta-1a (Rebif)","SUBGROUP_AND_OVERALL","TENERE 2014",2014,0,0,0,0,18,220,0,0,7,101,0,0,100,1.180519,0.50931,2.736305,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Ofatumumab versus placebo","SUBGROUP_AND_OVERALL","APOLITOS 2021",2021,0,0,0,0,1,43,0,0,0,21,0,0,45.404666,1.5,0.063675,35.335605,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Ofatumumab versus placebo","SUBGROUP_AND_OVERALL","MIRROR 2018",2018,0,0,0,0,5,164,0,0,0,67,0,0,54.595334,4.533333,0.25416,80.858902,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Glatiramer acetate versus interferon beta-1a (Rebif)","SUBGROUP_AND_OVERALL","REGARD 2008",2008,0,0,0,0,27,375,0,0,29,381,0,0,100,0.945931,0.57122,1.566445,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Ocrelizumab versus interferon beta-1a (Avonex)","SUBGROUP_AND_OVERALL","Kappos 2011",2011,0,0,0,0,4,110,0,0,2,54,0,0,100,0.981818,0.185594,5.193948,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Fingolimod versus interferon beta-1a (Avonex)","SUBGROUP_AND_OVERALL","TRANSFORMS 2010",2010,0,0,0,0,75,849,0,0,25,431,0,0,100,1.522968,0.983264,2.358911,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
1,1,"SAEs","Interferon beta-1a(Rebif) versus interferon beta-1a (Avonex)","SUBGROUP_AND_OVERALL","EVIDENCE 2002",2002,0,0,0,0,21,339,0,0,18,337,0,0,100,1.159784,0.629391,2.137144,NA,"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012186.pub2/full","10.1002/14651858.CD012186.pub2","1::overall","CD012186_pub2_data","significance_only",TRUE,FALSE,TRUE,0.0112301123855269,0.0056856309852699,-0.0556903822795576,0.0781506070506113,0.000265400725780735,0.0111058612447591,TRUE,TRUE
